Product class: Authorized package
Medicinal product class: For human use
Package code: 1165711
Name of medicinal product: ANGELIQ
Active substances:
Drospirenone+Estradiol
Estonian, English, Latin
ATC code: G03FA17
Dosage form: film-coated tablet
Route of administration: oral use
Strengh: 2mg+1mg
Amount in package: 28TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women more than 1 year post menopause. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (See also Section 4.4) The experience treating women older than 65 years is limited.
Safety features: Yes
Summary of product characteristics (SPC):  (last updated 16 February 2024)
Package information leaflet (PIL): EST  (last updated 16 February 2024)
Labelling:  (last updated 09 January 2018)
Last imported to Estonia: 22 May 2024
Marketing authorization holder: Bayer AG 
Marketing authorization number: 472405 
Marketing authorization issued on: 12 May 2005 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
100  05/04/2024     Yes      No  until 4 years   
50  05/04/2024     Yes      No      
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: 16 February 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription